October 20(Sun) 15:10-16:50 |
Symposium 1 mRNA Vaccine and Immunity |
Room A | ||
---|---|---|---|---|
Speaker(s) |
TBC
Annette Vogel (BioNTech SE, DEU) |
|||
B cell responses to vaccination: Lessons from the SARS-CoV-2 pandemic
Ali Ellebedy (Washington Univ., USA) |
||||
TBC
Galit Alter (Moderna, USA) |
October 20(Sun) 15:10-16:50 |
Symposium 2 IFNs and Inflammation |
Room B | ||
---|---|---|---|---|
Speaker(s) |
Positive and Negative Regulation of Interferon Signaling and Antiviral Immunity
Curt Horvath (Northwestern Univ., USA) |
|||
Molecular mechanisms of innate immunity and inflammation in health and disease
Thirumala-Devi Kanneganti (St. Jude Children's Hospital, USA) |
||||
Regulation of cancer immunity, spatial organization, and immunotherapy by interferons
David G Brooks (Univ. of Toronto, CAN) |
October 20(Sun) 16:50-17:40 |
Keynote | Room A | ||
---|---|---|---|---|
Speaker(s) |
Type 2 Cytokines: a story of Macrophages, Matrix & Metazoan Parasites
Judith Allen (The Univ. of Manchester, GBR) |
October 21(Mon) 08:30-10:10 |
Symposium 3 Host-Microbiota Interaction |
Room A | ||
---|---|---|---|---|
Speaker(s) |
Wild-derived microbiota regulate host immune responses and disease outcome in preclinical models
Barbara Rehermann (NIH, USA) |
|||
Microbiome Therapeutics for Inflammatory Disorders and Cancer
Sin-Hyeog Im (POSTECH, KOR) |
October 21(Mon) 08:30-10:10 |
Symposium 4 B cell and Cytokines |
Room B | ||
---|---|---|---|---|
Speaker(s) |
IL-4 and germinal center B cell selection
Marion Pepper (Univ. of Washington, USA) |
|||
Title: B cell immune responses in complex microenvironment
Ziv Shulman (Weizmann Institute of Science, ISR) |
||||
The impact of type I interferon dynamics on memory B cell subsets during infection
Kim Good-Jacobson (Monash Univ., AUS) |
October 21(Mon) 08:30-10:10 |
Symposium 5 KAI-AKIA |
Room C | ||
---|---|---|---|---|
Speaker(s) |
Dissecting host immune responses in situ
Jun Huh (Harvard Univ., USA) |
|||
CD103 preconditions naïve CD8 T cells for their acquisition of effector phenotype and function
Jung-Hyun Park (NIH/NCI, USA) |
||||
TBC
|
||||
TBC
|
October 21(Mon) 10:40-12:00 |
Symposium 6 Trained Immunity and Cytokines |
Room A | ||
---|---|---|---|---|
Speaker(s) |
Central Trained Immunity and Chronic Inflammation
George Hajishengallis (Univ. of Pennsylvania, USA) |
|||
Innate Immune Memory and the Aging Eye
Przemyslaw Sapieha (Centre de recherche HMR, FRA) |
October 21(Mon) 10:40-12:00 |
Symposium 7 Mucosal Immunity |
Room B | ||
---|---|---|---|---|
Speaker(s) |
Microbiota-regulation of Tumor-Associated Macrophages
Jorge Henao-Mejia (Univ. of Pennsylvania, USA) |
|||
Microbiota and immune responses in the stomach are involved in controlling various diseases
Naoko Satoh-Takayama (RIKEN, JPN) |
October 21(Mon) 10:40-12:00 |
Symposium 8 T cell Homeostasis and Cytokines (Charles D. Surh Memorial Session) |
Room C | ||
---|---|---|---|---|
Speaker(s) |
Fixing to generate new T cells (lessons learned from Charlie Surh, about golf, wine & cytokines)
Juan Carlos Zuniga-Pflucker (Univ. of Toronto, CAN) |
|||
Subsetting and shaping naive CD8 T cell pools with complex effector codes
Jae Ho Cho (Chonnam Univ, KOR) |
October 21(Mon) 16:20-18:00 |
Symposium 9 Tumor Immunology and Immunotherapy |
Room A | ||
---|---|---|---|---|
Speaker(s) |
Control of cytokine signaling to enhance efficacy and safety of CAR-T cell therapy
Yuki Kagoya (Keio Univ., JPN) |
|||
Shared mechanisms of Anti-PD1 efficacy in tumor, and toxicity in tissue
Niroshana Anandasabapathy (Cornell Univ., USA) |
||||
Functional Identification and Therapeutic Targeting of Cancer Neoantigens
Stephen Schoenberger (La Jolla Institute for Immunology, USA) |
October 21(Mon) 16:20-18:00 |
Symposium 10 Infection and Immunity |
Room B | ||
---|---|---|---|---|
Speaker(s) |
Differential innate antiviral signaling in human and bat cells
Karen Mossman (McMaster Univ., CAN) |
|||
Inflammasome sensing in inflammation and cancer
Si Ming Man (Australia National Univ., AUS) |
||||
Regulation of IL-15-induced NK-like activation of CD8+ T cells in viral infection
Eui-Cheol Shin (KAIST, KOR) |
October 21(Mon) 16:20-18:00 |
Guest Symposium Predicting virus associated inflammatory disease severity in children with laboratory diagnostics and artificial intelligence- PreVAIL kIds experience with SARS-CoV-2 infection syndrome including MIS-C |
Room C | ||
---|---|---|---|---|
Speaker(s) |
Analytics approaches to evaluate the contribution of biomarkers integrated into clinical prediction models
Cedric Manlhiot (Johns Hopkins University, USA) |
|||
ML derived unique cytokine/chemokine biosignature of MIS-C across SARS-CoV-2 variants
Ananth Annapragada (Texas Children's Hospital, USA) |
||||
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
Juan Salazar (Connecticut Children's Hospital, USA) |
||||
Multisystem inflammatory syndrome in children (MIS-C) induces a Toll-like receptor-tolerant phenotype in peripheral blood cells that is genetically modulated
Maria Gennaro (Rutgers University, USA) |
||||
Diagnosing and predicting risk in children with SARS-CoV-2 related illness
Jane Burns (University of California, San Diego, USA) |
||||
Host-based clinical assays for diagnosis and severity prediction of COVID-19 associated clinical syndromes including MIS-C
Charles Chiu (University of California, San Francisco, USA) |
October 22(Tue) 08:30-10:10 |
Symposium 11 Cytokine Engineering |
Room A | ||
---|---|---|---|---|
Speaker(s) |
Molecular modulation of interleukin-2 for next-generation immunotherapy
Onur Boyman (Univ. of Zurich, CHE) |
|||
Protein engineering efforts enable the production of IFNλ4, the solution of the receptor complex by cryoEM, and provide insights into its differential activity
Juan Mendoza (Univ Chicago, USA) |
||||
Targeting tumor microenvironment with engineered cytokines
Yang-Xin Fu (Tsinghua Univ., CHN) |
October 22(Tue) 08:30-10:10 |
Symposium 12 Immune Regulation of Inflammatory Diseases |
Room B | ||
---|---|---|---|---|
Speaker(s) |
Transcription factor NFAT5 is essential to chronic inflammatory diseases
Wan-Uk Kim (Catholic Univ., KOR) |
|||
Metabolic Checkpoints in Autoimmune Tissue Inflammation
Cornelia M. Weyand (Mayo Clinic, USA) |
||||
Role of MIF in the Glucocorticoid Regulation of Immune Responsiveness
Richard J. Bucala (Yale Univ. School of Medicine, USA) |
October 22(Tue) 10:40-12:00 |
Symposium 13 Cytokines and Myeloid Cells |
Room A | ||
---|---|---|---|---|
Speaker(s) |
Neutrophil heterogeneity at steady state and stress conditions
Lai Guan Ng (Singapore Immunology Network(SIgN), A*STAR, SGP) |
|||
Transcriptional and spatial control of macrophages in cancer
Renato Ostuni (Università Vita-Salute San Raffaele, ITA) |
October 22(Tue) 10:40-12:00 |
Symposium 14 Cytokines and CD8 T cell Immunity |
Room B | ||
---|---|---|---|---|
Speaker(s) |
T cell differentiation and function in chronic infection and cancer
Axel Kallies (Univ. of Melbourne, AUS) |
|||
Costimulation modulates the PD-1+ CD8 T cells beyond priming
Alice Kamphorst (Mount Sainai, USA) |
October 22(Tue) 10:40-12:00 |
Symposium 15 Immune Regulation of Tissue Repair |
Room C | ||
---|---|---|---|---|
Speaker(s) |
Fibroblast orchestration of tissue resident lymphocytes in disease and aging
Tien Peng (Univ. of California, San Francisco, USA) |
|||
Immune-mediated mechanisms of adaptive and maladaptive tissue responses
Shruti Naik (New York Univ., USA) |
October 22(Tue) 16:20-18:00 |
Symposium 16 Type 2 Immunity and Airway Diseases |
Room A | ||
---|---|---|---|---|
Speaker(s) |
Regulating type 2 cytokine production from T follicular helper cells
Stephanie Eisenbarth (Northwestern Univ., USA) |
|||
ILCs at the Crossroads: Understanding their Influence in Type 2 Immunity and Airway Disorders
Hye-Young Kim (Seoul National Univ., KOR) |
||||
The regulation and role lung resident and lymphoid T follicular helper cells in allergic airways disease
James Harker (Imperial College London, GBR) |
October 22(Tue) 16:20-18:00 |
Symposium 17 Clinical Immunology of Autoimmune Diseases |
Room B | ||
---|---|---|---|---|
Speaker(s) |
The role of cytokine receptors in identifying T cell subsets in health and disease
Insoo Kang (Yale Univ. School of Medicine, USA) |
|||
Mechanism-based cytokine-targeting therapies and precision medicine in rheumatic diseases
Yoshiya Tanaka (Univ. of Occupational and Environmental Health, JPN) |
||||
Integrative Functional Genomics Reveals the Determinants of Age/Autoimmune-Associated B Cells (ABCs)
Nan Shen (Shanghai Jiao Tong Univ. School of Medicine, CHN) |
October 22(Tue) 16:20-18:00 |
Guest Symposium Lambda IFN |
Room C | ||
---|---|---|---|---|
Speaker(s) |
IFN-λ controls intestinal repair in IBD
Achille Broggi (CIML, FRA) |
|||
STING dependent induction of type III IFN subtypes
Megan Stanifer (Univ. of Florida, USA) |
||||
Single cell sequencing of influenza virus infected primary human alveolar macrophages reveals a powerful Interferon Lambda response
Rune Hartmann (Aarhus Univ., DNK) |
||||
Viral exploitation of the programmed cell death for evasion of IFN-Lambda immunity
Sanghyun Lee (Brown Univ., USA) |
||||
Regulation of antiviral immunity in the intestinal epithelium
Tim Nice (OHSU, USA) |
October 23(Wed) 08:30-10:10 |
Symposium 18 Cytokine-blockade Therapy of Human Diseases |
Room A | ||
---|---|---|---|---|
Speaker(s) |
Anti-T2 biologics in severe asthma
Ian Adcock (Imperial College London, GBR) |
|||
Role of CXCR6+CD4+ Tissue-Resident Memory T Cells in Chronic Allergic Skin Inflammation
Kenji Kabashima (Kyoto Univ., JPN) |
||||
The multifaceted contribution of the BAFF/APRIL system to Chronic Lymphocytic Leukemia progression
Fabienne Mackay (QIMR Berghofer Medical Research Institute, AUS) |
October 23(Wed) 08:30-10:10 |
Symposium 19 Cytokines in T helper Differentiation and Function |
Room B | ||
---|---|---|---|---|
Speaker(s) |
Gene dosage control by multi-enhancer hub formation
Golnaz Vahedi (Univ. of Pennsylvania, USA) |
|||
Neuronal Control of Cutaneous Inflammation
Daniel Kaplan (Univ. of Pittsburgh, USA) |
||||
Non-canonical regulation of IL-21 bioavailability and activity
Di Yu (The Univ. of Queensland, AUS) |
October 23(Wed) 13:30-14:30 |
Keynote | Room A | ||
---|---|---|---|---|
Speaker(s) |
Nucleoside Modified mRNA-LNP Therapeutics
Drew Weissman (Univ. of Pennsylvania, USA) |